Portfolio company TidalSense raised £14.2m to accelerate commercial expansion of its AI-powered respiratory diagnostic device.
TidalSense is a venture-backed respiratory technology company focused on transforming respiratory care pathways through AI-driven diagnostic and monitoring technologies, particularly for COPD and asthma
TidalSense is a venture-backed respiratory technology company focused on transforming respiratory care pathways through AI-driven diagnostic and monitoring technologies, particularly for COPD and asthma.